Akums Drugs and Pharmaceuticals Ltd has received European Good Manufacturing Practice (GMP) certificates for its two facilities in Haridwar. This recognition strengthens Akums’ global credibility, enabling it to expand exports to regulated markets. The certification underscores the company’s commitment to quality, compliance, and international standards in pharmaceutical manufacturing
Akums Drugs and Pharmaceuticals Ltd, one of India’s largest contract manufacturing companies in the pharmaceutical sector, announced that its two Haridwar facilities have been awarded European GMP certificates. This achievement marks a significant milestone in the company’s journey toward global expansion and compliance with international quality standards.
Key Highlights:
-
Certification Awarded: Two Haridwar facilities of Akums have received European GMP certification.
-
Global Standards: GMP certification ensures adherence to stringent international manufacturing and quality protocols.
-
Export Potential: The recognition opens doors for Akums to expand its footprint in regulated European markets.
-
Quality Commitment: Reinforces Akums’ dedication to producing safe, effective, and reliable pharmaceutical products.
-
Strategic Impact: Strengthens the company’s position as a trusted partner for global pharmaceutical companies seeking contract manufacturing solutions.
This certification not only enhances Akums’ credibility but also positions it as a key contributor to India’s growing pharmaceutical exports, aligning with the nation’s vision of becoming a global pharma hub.
Sources: Reuters, BSE India, Akums Drugs and Pharmaceuticals Ltd official filings